|
.
See Category: Endocrine, nutritional and metabolic diseases
See Header: Multiple endocrine neoplasia [MEN] syndromes
ICD-10 (CM) Code and Descriptor
E31.23 |
Multiple endocrine neoplasia [MEN] type IIB
|
E3123 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 13 |
32.18%
|
25.29%
|
12.64%
|
10.34%
|
6.90%
|
4.60%
|
1.15%
|
1.15%
|
1.15%
|
3.45%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for E31.23*:
CPT |
Description |
Number of Claims |
Sum Performed |
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
5
|
5
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
5
|
5
|
82308
|
ASSAY OF CALCITONIN |
4
|
4
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
3
|
3
|
80048
|
METABOLIC PANEL TOTAL CA |
3
|
3
|
84443
|
ASSAY THYROID STIM HORMONE |
3
|
3
|
Q3014
|
TELEHEALTH FACILITY FEE |
3
|
3
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
2
|
2
|
83835
|
ASSAY OF METANEPHRINES |
2
|
2
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2
|
2
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
1
|
2
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
1
|
60
|
82024
|
ASSAY OF ACTH |
1
|
1
|
82040
|
ASSAY OF SERUM ALBUMIN |
1
|
1
|
84244
|
ASSAY OF RENIN |
1
|
1
|
82306
|
VITAMIN D 25 HYDROXY |
1
|
1
|
83970
|
ASSAY OF PARATHORMONE |
1
|
1
|
84439
|
ASSAY OF FREE THYROXINE |
1
|
1
|
84481
|
FREE ASSAY (FT-3) |
1
|
1
|
83880
|
ASSAY OF NATRIURETIC PEPTIDE |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
E31.23 related to the following DRG Codes:
643-645
|